5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer

AIMS: 5-FU is used as the main backbone of chemotherapy regimens for patients with colorectal and other gastrointestinal cancers. Despite development of new strategies that allowed enhancing clinical effectiveness and tolerability of 5-FU, 10–30% of patients treated with 5-FU-based regimens experien...

Descripción completa

Detalles Bibliográficos
Autores principales: Morawska, Katarzyna, Goirand, Françoise, Marceau, Laurine, Devaux, Madeline, Cueff, Adèle, Bertaut, Aurélie, Vincent, Julie, Bengrine-Lefevre, Leila, Ghiringhelli, François, Schmitt, Antonin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837758/
https://www.ncbi.nlm.nih.gov/pubmed/29545919
http://dx.doi.org/10.18632/oncotarget.24338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837758/
https://www.ncbi.nlm.nih.gov/pubmed/29545919
http://dx.doi.org/10.18632/oncotarget.24338

Ejemplares similares